ABX Fundamental Analysis - ADVANCED BLOCKCHAIN AG

Fundamental Rating

Taking everything into account, ABX scores 3 out of 10 in our fundamental rating. ABX was compared to 115 industry peers in the Software industry. Both the profitability and the financial health of ABX get a neutral evaluation. Nothing too spectacular is happening here. ABX has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

ABX had positive earnings in the past year.

In the past 5 years ABX reported 4 times negative net income.

ABX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

ABX has a Return On Assets of 17.76%. This is amongst the best in the industry. ABX outperforms 93.91% of its industry peers.

With an excellent Return On Equity value of 26.00%, ABX belongs to the best of the industry, outperforming 86.09% of the companies in the same industry.

With an excellent Return On Invested Capital value of 19.38%, ABX belongs to the best of the industry, outperforming 89.57% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	17.76%
ROE	26%
ROIC	19.38%

ROA(3y)4.93%

ROA(5y)-0.61%

ROE(3y)8.17%

ROE(5y)0.86%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ABX has a better Profit Margin (38.48%) than 93.91% of its industry peers.

The Operating Margin of ABX (56.80%) is better than 97.39% of its industry peers.

With a Gross Margin value of 54.80%, ABX is not doing good in the industry: 69.57% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
OM	56.8%
PM (TTM)	38.48%
GM	54.8%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, ABX has less shares outstanding

Compared to 5 years ago, ABX has more shares outstanding

The debt/assets ratio for ABX is higher compared to a year ago.

2.2 Solvency

ABX has an Altman-Z score of 3.98. This indicates that ABX is financially healthy and has little risk of bankruptcy at the moment.

ABX has a Altman-Z score (3.98) which is comparable to the rest of the industry.

A Debt/Equity ratio of 0.26 indicates that ABX is not too dependend on debt financing.

ABX has a Debt to Equity ratio (0.26) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.26
Debt/FCF	N/A
Altman-Z	3.98

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

ABX has a Current Ratio of 17.91. This indicates that ABX is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 17.91, ABX belongs to the top of the industry, outperforming 97.39% of the companies in the same industry.

A Quick Ratio of 17.91 indicates that ABX has no problem at all paying its short term obligations.

ABX has a Quick ratio of 17.91. This is amongst the best in the industry. ABX outperforms 97.39% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	17.91
Quick Ratio	17.91

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ABX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.63%.

ABX shows a strong growth in Revenue. In the last year, the Revenue has grown by 99.72%.

Measured over the past years, ABX shows a very negative growth in Revenue. The Revenue has been decreasing by -11.52% on average per year.

EPS 1Y (TTM)-1.63%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-106.27%

Revenue 1Y (TTM)99.72%

Revenue growth 3Y-54.09%

Revenue growth 5Y-11.52%

Sales Q2Q%-97.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-438.46%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 3.60, the valuation of ABX can be described as very cheap.

98.26% of the companies in the same industry are more expensive than ABX, based on the Price/Earnings ratio.

Compared to an average S&P500 Price/Earnings ratio of 26.38, ABX is valued rather cheaply.

The Forward Price/Earnings Ratio is negative for ABX. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	3.6
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ABX!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

ADVANCED BLOCKCHAIN AG

FRA:ABX (12/18/2025, 7:00:00 PM)

2.63

+0.03 (+1.15%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.2%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap10.68M

Revenue(TTM)6.46M

Net Income(TTM)2.49M

Analysts84

Price Target3.87 (47.15%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-64.74%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	3.6
Fwd PE	N/A
P/S	1.65
P/FCF	N/A
P/OCF	N/A
P/B	1.09
P/tB	1.09
EV/EBITDA	N/A

EPS(TTM)0.73

EY27.76%

EPS(NY)-0.44

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS1.59

BVpS2.42

TBVpS2.42

PEG (NY)N/A

PEG (5Y)N/A

Graham Number6.31

Profitability

		Industry Rank	Sector Rank
ROA	17.76%
ROE	26%
ROCE	27.52%
ROIC	19.38%
ROICexc	19.38%
ROICexgc	19.42%
OM	56.8%
PM (TTM)	38.48%
GM	54.8%
FCFM	N/A

ROA(3y)4.93%

ROA(5y)-0.61%

ROE(3y)8.17%

ROE(5y)0.86%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-ScoreN/A

Asset Turnover0.46

Health

		Industry Rank	Sector Rank
Debt/Equity	0.26
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	17.91
Quick Ratio	17.91
Altman-Z	3.98

F-ScoreN/A

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-1.63%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-106.27%

EPS Next Y-438.46%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)99.72%

Revenue growth 3Y-54.09%

Revenue growth 5Y-11.52%

Sales Q2Q%-97.4%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y113.57%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-300%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

ADVANCED BLOCKCHAIN AG / ABX.DE FAQ

Can you provide the ChartMill fundamental rating for ADVANCED BLOCKCHAIN AG?

ChartMill assigns a fundamental rating of 3 / 10 to ABX.DE.

What is the valuation status of ADVANCED BLOCKCHAIN AG (ABX.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to ADVANCED BLOCKCHAIN AG (ABX.DE). This can be considered as Overvalued.

How profitable is ADVANCED BLOCKCHAIN AG (ABX.DE) stock?

ADVANCED BLOCKCHAIN AG (ABX.DE) has a profitability rating of 4 / 10.

What is the valuation of ADVANCED BLOCKCHAIN AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ADVANCED BLOCKCHAIN AG (ABX.DE) is 3.6 and the Price/Book (PB) ratio is 1.09.

ADVANCED BLOCKCHAIN AG (ABX.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

ADVANCED BLOCKCHAIN AG / ABX.DE FAQ

Can you provide the ChartMill fundamental rating for ADVANCED BLOCKCHAIN AG?

What is the valuation status of ADVANCED BLOCKCHAIN AG (ABX.DE) stock?

How profitable is ADVANCED BLOCKCHAIN AG (ABX.DE) stock?

What is the valuation of ADVANCED BLOCKCHAIN AG based on its PE and PB ratios?